FDA — authorised 25 August 2005
- Application: ANDA065250
- Marketing authorisation holder: ANI PHARMS
- Local brand name: CLARITHROMYCIN
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA authorised Klaricid on 25 August 2005
Yes. FDA authorised it on 25 August 2005; FDA authorised it on 31 May 2006; FDA authorised it on 4 September 2007.
ANI PHARMS holds the US marketing authorisation.